drugset / Trial / NCT05855395

The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19

NCT05855395

Unknown 5815 enrolled Huashan Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is aimed to explore the dual-dimensional early intervention strategy of standard of care combined with host immunomodulation in elderly patients with mild and moderate COVID-19.

Timeline

Start
2023-05-26
Primary completion
2024-05-01
Completion
2024-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 3 mg Oral
Subject Methylprednisolone Other / unclassified 16 mg Oral
Subject Prednisone Other / unclassified 20 mg Oral

Indications